Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia.

Follin, Cecilia; Thilén, Ulf; Ahrén, Bo; Erfurth, Eva Marie.
J Clin Endocrinol Metab; 91(5): 1872-5, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16522695